Cyrano Therapeutics, Inc.
Biotechnology company · Washington, District of Columbia, United States
Cyrano Therapeutics, Inc. is a biotechnology company headquartered in Washington, District of Columbia, United States. It has reported private securities offerings to the US SEC, most recently $4.1 million sold in a notice filed in 2020.
Profile compiled from public records. Is this your company? Request a correction or update
Cyrano Therapeutics at a glance
Typebiotechnology company
HeadquartersWashington, District of Columbia, United States
SEC CIK1832334
What does Cyrano Therapeutics do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $4.1 million sold (2020).
Frequently asked questions about Cyrano Therapeutics
Where is Cyrano Therapeutics headquartered?
Cyrano Therapeutics, Inc. is headquartered in Washington, District of Columbia, United States.
What does Cyrano Therapeutics do?
Cyrano Therapeutics, Inc. is a biotechnology company.
Similar companies
- Vitakey Inc.Washington, District of Columbia, United States
- Floreo, Inc.Washington, District of Columbia, United States
- OncovirWashington, District of Columbia, United States
- Nanochon, Inc.Washington, District of Columbia, United States
- Media Rez LLCWashington, District of Columbia, United States
- Amelia Technologies LLCWashington, District of Columbia, United States
- Neuroene Therapeutics IncWashington, District of Columbia, United States
- Openbeds Inc.Washington, District of Columbia, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences